Lily C. Chao

3.9k total citations
40 papers, 2.3k citations indexed

About

Lily C. Chao is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lily C. Chao has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Lily C. Chao's work include Diabetes Management and Research (15 papers), Diabetes and associated disorders (10 papers) and Pancreatic function and diabetes (10 papers). Lily C. Chao is often cited by papers focused on Diabetes Management and Research (15 papers), Diabetes and associated disorders (10 papers) and Pancreatic function and diabetes (10 papers). Lily C. Chao collaborates with scholars based in United States, Australia and France. Lily C. Chao's co-authors include Peter Tontonoz, Kevin Wroblewski, Damien C. Wilpitz, Bryan Laffitte, Sarah Hummasti, Oksana Gavrilova, Marc L. Reitman, Enrique Sáez, Jaideep Moitra and Elif Arioǧlu and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lily C. Chao

35 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily C. Chao United States 22 1.2k 593 564 490 427 40 2.3k
Caleb B. Kallen United States 22 1.8k 1.5× 290 0.5× 530 0.9× 110 0.2× 446 1.0× 38 3.1k
Antti Virkamäki Finland 24 1.5k 1.3× 626 1.1× 858 1.5× 120 0.2× 741 1.7× 33 3.0k
Bruno Lefebvre France 26 1.2k 1.0× 305 0.5× 517 0.9× 216 0.4× 119 0.3× 47 2.2k
Ann Louise Olson United States 35 2.6k 2.2× 889 1.5× 1.2k 2.0× 123 0.3× 379 0.9× 65 3.7k
Kiyoshi Teshigawara Japan 23 803 0.7× 314 0.5× 317 0.6× 109 0.2× 230 0.5× 55 2.1k
Fabienne Rajas France 31 1.3k 1.1× 703 1.2× 1.1k 2.0× 92 0.2× 675 1.6× 80 3.1k
Reinhart Kluge Germany 29 853 0.7× 456 0.8× 555 1.0× 97 0.2× 207 0.5× 51 2.0k
James A. Van Rhee United States 11 2.0k 1.7× 396 0.7× 1.3k 2.3× 129 0.3× 223 0.5× 28 3.0k
Robert Augustin Germany 25 982 0.8× 431 0.7× 376 0.7× 116 0.2× 620 1.5× 36 2.1k
Michèle Sweeney United States 18 1.2k 1.0× 416 0.7× 477 0.8× 299 0.6× 78 0.2× 25 2.5k

Countries citing papers authored by Lily C. Chao

Since Specialization
Citations

This map shows the geographic impact of Lily C. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily C. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily C. Chao more than expected).

Fields of papers citing papers by Lily C. Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily C. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily C. Chao. The network helps show where Lily C. Chao may publish in the future.

Co-authorship network of co-authors of Lily C. Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Lily C. Chao. A scholar is included among the top collaborators of Lily C. Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily C. Chao. Lily C. Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hannon, Tamara S., Lily C. Chao, Margarita Barrientos‐Pérez, et al.. (2025). Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 406(10511). 1484–1496. 2 indexed citations
2.
Miyazaki, Brian, et al.. (2024). Expansion of Medicaid Coverage of Continuous Glucose Monitor Reduces Health Disparity in Children and Young Adults With Type 1 Diabetes. Journal of Diabetes Science and Technology. 570896433–570896433.
3.
Nadeau, Kristen J., Silva Arslanian, Fida Bacha, et al.. (2024). Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 68(3). 676–687. 1 indexed citations
4.
Everett, Estelle, Timothy P. Copeland, Lauren E. Wisk, & Lily C. Chao. (2023). Risk Factors for Hyperosmolar Hyperglycemic State in Pediatric Type 2 Diabetes. Pediatric Diabetes. 2023. 1–7. 4 indexed citations
5.
Vidmar, Alaina P., et al.. (2023). Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth. touchREVIEWS in Endocrinology. 19(1). 38–38. 9 indexed citations
6.
7.
Nadeau, Kristen J., Laure El ghormli, Silva Arslanian, et al.. (2023). Effect of Early Glycemic Control in Youth-Onset Type 2 Diabetes on Longer-Term Glycemic Control and β-Cell Function: Results From the TODAY Study. Diabetes Care. 46(8). 1507–1514. 5 indexed citations
8.
Vidmar, Alaina P., et al.. (2023). Association Between COVID-19 and Severity of Illness for Children With Hyperglycemic Crisis. Hospital Pediatrics. 13(9). 794–801. 1 indexed citations
9.
Trief, Paula M., Diane Uschner, Marsha D. Marcus, et al.. (2022). Diabetes Distress in Young Adults With Youth-Onset Type 2 Diabetes: TODAY2 Study Results. Diabetes Care. 45(3). 529–537. 20 indexed citations
10.
Bjornstad, Petter, Lily C. Chao, Melanie Cree‐Green, et al.. (2022). Youth-onset type 2 diabetes mellitus: an urgent challenge. Nature Reviews Nephrology. 19(3). 168–184. 58 indexed citations
11.
Arslanian, Silva, Tamara S. Hannon, Philip Zeitler, et al.. (2022). Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes. New England Journal of Medicine. 387(5). 433–443. 80 indexed citations
12.
Chao, Lily C., Alaina P. Vidmar, & Senta Georgia. (2021). Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic. Diabetes Care. 44(6). 1451–1453. 43 indexed citations
13.
Chao, Lily C., et al.. (2021). Impact of COVID-19 on Youth With Type 2 Diabetes: Lessons Learned From a Pediatric Endocrinologist and a Psychologist. Frontiers in Endocrinology. 12. 650492–650492. 2 indexed citations
14.
Chang, Nancy, et al.. (2020). Glycemic control in youth‐onset type 2 diabetes correlates with weight loss. Pediatric Diabetes. 21(7). 1116–1125. 9 indexed citations
15.
Beaven, Simon W., Aleksey V. Matveyenko, Kevin Wroblewski, et al.. (2013). Reciprocal Regulation of Hepatic and Adipose Lipogenesis by Liver X Receptors in Obesity and Insulin Resistance. Cell Metabolism. 18(1). 106–117. 118 indexed citations
16.
Chao, Lily C., Cynthia Hong, Ayaka Ito, et al.. (2013). Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice. Journal of Lipid Research. 54(3). 806–815. 50 indexed citations
17.
Villanueva, Claudio J., Hironori Waki, Cristina Godio, et al.. (2011). TLE3 Is a Dual-Function Transcriptional Coregulator of Adipogenesis. Cell Metabolism. 13(4). 413–427. 124 indexed citations
18.
Hummasti, Sarah, Bryan Laffitte, Michael A. Watson, et al.. (2004). Liver X receptors are regulators of adipocyte gene expression but not differentiation. Journal of Lipid Research. 45(4). 616–625. 99 indexed citations
19.
Chao, Lily C., Amer Jamil, Steven J. Kim, Lisa Huang, & Harold G. Martinson. (1999). Assembly of the Cleavage and Polyadenylation Apparatus Requires About 10 Seconds In Vivo and Is Faster for Strong than for Weak Poly(A) Sites. Molecular and Cellular Biology. 19(8). 5588–5600. 38 indexed citations
20.
Yeung, George, Lily C. Chao, Noh Jin Park, et al.. (1998). Poly(A)-Driven and Poly(A)-Assisted Termination: Two Different Modes of Poly(A)-Dependent Transcription Termination. Molecular and Cellular Biology. 18(1). 276–289. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caleb B. Kallen Breakdown of academic impact, for papers by Antti Virkamäki Breakdown of academic impact, for papers by Bruno Lefebvre Breakdown of academic impact, for papers by Ann Louise Olson Breakdown of academic impact, for papers by Kiyoshi Teshigawara Breakdown of academic impact, for papers by Fabienne Rajas Breakdown of academic impact, for papers by Reinhart Kluge Breakdown of academic impact, for papers by James A. Van Rhee Breakdown of academic impact, for papers by Robert Augustin Breakdown of academic impact, for papers by Michèle Sweeney
Rankless by CCL
2026